Vertex Pharmaceuticals (VRTX) stock gets an upgrade from Canaccord Genuity after its Q4 2024 results on Tuesday, Read more here.

This third generation of the company's 3nm technology is expected to offer a 5 percent improvement in performance and 5-10 percent better power efficiency than the M4 chip's N3E process.

We recently compiled a list of the 35 Chip Stocks In Focus Amid Tech Selloff ... HBM, essential for AI and high-performance computing (HPC), is expected to grow at a 64% compound annual growth ...

Vertex provided 2025 revenue guidance of $11.75 billion to $12 billion, reflecting 8% growth at the midpoint. Growth is expected from U.S. launches of ALYFTREK and JOURNAVX, along with the continued ...

The Grammy-winning R&B star, who previously boycotted the awards show after being snubbed in 2021, gave a surprise performance at ... Play the USA TODAY Daily Crossword Puzzle.

SAN FRANCISCO/NEW YORK, Feb 10 (Reuters) - OpenAI is pushing ahead on its plan to reduce its reliance on Nvidia (NVDA.O), opens new tab for its chip supply by developing its first generation of in ...

The vivacious and engaging Daigle took some time after her Super Bowl press conference this week to talk to USA TODAY about what ... isn’t your first Superdome performance, but might it be ...

Piper Sandler expressed continued confidence in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), maintaining an Overweight ...

The approval marks a significant step for Lupin in the US market. Jan 09, 2025 17:38 Vertex Global Services Partners with Arish Global Services for Job Creation Vertex Global Services partners with UK ...

The 2025 Super Bowl began with an absolutely incredible performance of the national anthem from New Orleans native Jon Batiste and absolutely no one is surprised. The Grammy and Oscar-winner put ...